Details of the Drug

General Information of Drug (ID: DM8NDI7)

Drug Name
AM-101
Indication
Disease Entry ICD 11 Status REF
Tinnitus MC41 Phase 3 [1]
Structure
3D MOL is unavailable 2D MOL
Chemical Identifiers
Formula
C13H17Cl2NO
Canonical SMILES
CNC1(CCCCC1=O)C2=CC=CC=C2Cl.Cl
InChI
1S/C13H16ClNO.ClH/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14;/h2-3,6-7,15H,4-5,8-9H2,1H3;1H/t13-;/m0./s1
InChIKey
VCMGMSHEPQENPE-ZOWNYOTGSA-N
Cross-matching ID
PubChem CID
44632368
ChEBI ID
CHEBI:60800
CAS Number
33643-47-9
TTD ID
D0Q8WX

References

1 ClinicalTrials.gov (NCT01803646) AM-101 in the Treatment of Acute Tinnitus 2. U.S. National Institutes of Health.